Edaravone and its clinical development for amyotrophic lateral sclerosis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Edaravone and its clinical development for amyotrophic lateral sclerosis
Authors
Keywords
-
Journal
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Volume 18, Issue sup1, Pages 5-10
Publisher
Informa UK Limited
Online
2017-09-06
DOI
10.1080/21678421.2017.1353101
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
- (2017) Koji Abe et al. LANCET NEUROLOGY
- Open-label 24-week extension study of edaravone (MCI-186) in amyotrophic lateral sclerosis
- (2017) Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Exploratory double-blind, parallel-group, placebo-controlled study of edaravone (MCI-186) in amyotrophic lateral sclerosis (Japan ALS severity classification: Grade 3, requiring assistance for eating, excretion or ambulation)
- (2017) Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- A post-hoc subgroup analysis of outcomes in the first phase III clinical study of edaravone (MCI-186) in amyotrophic lateral sclerosis
- (2017) Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Exploratory double-blind, parallel-group, placebo-controlled extension study of edaravone (MCI-186) in amyotrophic lateral sclerosis
- (2017) Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Edaravone, a potent free radical scavenger, reacts with peroxynitrite to produce predominantly 4-NO-edaravone
- (2016) Akio Fujisawa et al. REDOX REPORT
- Gly482Ser PGC-1α Gene Polymorphism and Exercise-Related Oxidative Stress in Amyotrophic Lateral Sclerosis Patients
- (2016) Angelique Pasquinelli et al. Frontiers in Cellular Neuroscience
- A multiple free-radical scavenging (MULTIS) study on the antioxidant capacity of a neuroprotective drug, edaravone as compared with uric acid, glutathione, and trolox
- (2014) Erisa Kamogawa et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Anti-inflammatory effects of Edaravone and Scutellarin in activated microglia in experimentally induced ischemia injury in rats and in BV-2 microglia
- (2014) Yun Yuan et al. BMC NEUROSCIENCE
- Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?
- (2014) Hiroshi Mitsumoto et al. LANCET NEUROLOGY
- Lack of Association between Nuclear Factor Erythroid-Derived 2-Like 2 Promoter Gene Polymorphisms and Oxidative Stress Biomarkers in Amyotrophic Lateral Sclerosis Patients
- (2014) Annalisa LoGerfo et al. Oxidative Medicine and Cellular Longevity
- Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients
- (2014) Koji Abe et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis
- (2013) Emanuele D’Amico et al. FREE RADICAL BIOLOGY AND MEDICINE
- 3-Nitrotyrosine: A biomarker of nitrogen free radical species modified proteins in systemic autoimmunogenic conditions
- (2013) Haseeb Ahsan HUMAN IMMUNOLOGY
- Redox Regulation in Amyotrophic Lateral Sclerosis
- (2013) Sonam Parakh et al. Oxidative Medicine and Cellular Longevity
- Oxidative Stress Interferes With White Matter Renewal After Prolonged Cerebral Hypoperfusion in Mice
- (2013) Nobukazu Miyamoto et al. STROKE
- The Role of Oxidative Stress in Amyotrophic Lateral Sclerosis and Parkinson’s Disease
- (2010) Athan Baillet et al. NEUROCHEMICAL RESEARCH
- Edaravone, a free radical scavenger, protects components of the neurovascular unit against oxidative stress in vitro
- (2009) Brian J. Lee et al. BRAIN RESEARCH
- Oxidative stress biomarkers in sporadic ALS
- (2008) Hiroshi Mitsumoto et al. Amyotrophic Lateral Sclerosis
- Increased mitochondrial oxidative damage in patients with sporadic amyotrophic lateral sclerosis
- (2007) Takahiko Murata et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started